OCPM Immunotherapeutic Vaccine

OCPM Immunotherapeutic Vaccine is a cancer peptide vaccine designed as an immunotherapy for the treatment of cancer. It is administered in combination with GM-CSF (granulocyte-macrophage colony-stimulating factor) as an adjuvant to enhance immune response. The vaccine aims to stimulate the patient's immune system to recognize and attack tumor cells by presenting specific cancer-associated peptides, thereby inducing a targeted antitumor immune response. The primary indication investigated was for patients with ovarian epithelial carcinoma, fallopian tube carcinoma, or primary peritoneal carcinoma following standard therapy[1]. The developer and manufacturer details are not specified in available sources.